Results 151 to 160 of about 27,164 (223)

Misdiagnosis of spinocerebellar ataxia type 3 as persistent postural-perceptual dizziness: A case report. [PDF]

Medicine (Baltimore)
Zhang Y, Chen X, Pan S.
europepmc   +1 more source

Ataxin-3 Overexpression via Adeno-associated Viral Vector Injection in the Primate Cerebellum: A Novel Model of Spinocerebellar Ataxia Type 3. [PDF]

Exp Neurobiol
Kim K, Kim A, Won J, Park J, Lim KS, Jeon CY, Min J, Cho JH, Song Y, Koo BS, Bae GS, Jeon E, Jeong KJ, Park SH, Lee HY, Choi WS, Lee DS, Lee Y.   +17 more
europepmc   +1 more source

Altered Brain Iron Depositions of Spinocerebellar Ataxia Type 3: From Pre-Symptomatic to Symptomatic Stage. [PDF]

Eur J Neurol
Qiu H, Hu M, Jiang C, Wu J, Huang Z, Liang J, Sha R, Zeng W, Wu C, Chu J, Zhao J.   +10 more
europepmc   +1 more source

Transcranial alternating current stimulation for treating spinocerebellar ataxia type 3: A randomized controlled trial. [PDF]

Cell Rep Med
Chen X, Liu X, Lin W, Zhang L, Cheng X, Huang Z, Zhang W, Zeng H, Lian Y, Zhang Y, Li M, Chen N, Huang S, Wang Z, Wang X, Liu Z, Yuan R, Chen X, Ye Z, Cheng B, Zhang Y, Chen Q, Wang D, Ni J, Wang N, Fu Y, Gan S, OSCCAR Investigators.   +27 more
europepmc   +1 more source

“Mimicking” capacity of spinocerebellar ataxia type 3: The details matter

Journal of the Neurological Sciences, 2013
Conceição, Bettencourt, Manuela, Lima
openaire   +2 more sources

Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohort. [PDF]

Lancet Reg Health Eur
Berger M, Garcia-Moreno H, Ferreira M, Hubener-Schmid J, Schaprian T, Wegner P, Elter T, Teichmann KM, Santana MM, Grobe-Einsler M, Oender D, Koyak BSC, Bernsen S, Pereira de Almeida L, Silva P, Ribeiro JA, Cunha I, Gonzalez-Robles C, Khan S, Heslegrave A, Zetterberg H, Lima M, Raposo M, Ferreira AF, Vasconcelos J, van de Warrenburg BP, van Gaalen J, van Prooije TH, de Vries J, Schols L, Riess O, Synofzik M, Timmann D, Thieme A, Erdlenbruch F, Infante J, Pelayo-Negro AL, Manrique L, Reetz K, Dogan I, Oz G, Joers JM, Bushara K, Onyike C, Povazan M, Jacobi H, Schmahmann JD, Ratai EM, Schmid M, Giunti P, Klockgether T, Faber J.   +51 more
europepmc   +1 more source

Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. [PDF]

BMC Neurol
Liu C, Wang X, Xu C, Liu X, Ke L, Li Y, Zhang H, Tan J, Tan S, Zhang Z, Cheng L, Ren Y, Shi L.   +12 more
europepmc   +1 more source

Beyond the cerebellum: perivascular space burden in spinocerebellar ataxia type 3 extends to multiple brain regions. [PDF]

Brain Commun
Huang Y, Zhen Z, Deng L, Ou P, Shi L, Shi F, Hua R, Wu J, Chen W, Wen R, Wang J, Liu C.   +11 more
europepmc   +1 more source

Long-term globus pallidus internus deep brain stimulation in a young patient with spinocerebellar ataxia type 3 initially presenting with levodopa-responsive parkinsonism: a 6-year follow-up case report and literature review. [PDF]

Ther Adv Neurol Disord
Zhao J, Ma S, Gao Y, Chen J, Chen J, Shi C, Wang P, Li J, Du J, Wan Z.   +9 more
europepmc   +1 more source

Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3. [PDF]

J Neurol
Elter TL, Sturm D, Santana MM, Schaprian T, Raposo M, Melo ARV, Lima M, Koyak B, Oender D, Grobe-Einsler M, Lopes S, Silva P, de Almeida LP, Giunti P, Garcia-Moreno H, Nethisinhe S, de Vries J, van de Warrenburg BP, van Gaalen J, Synofzik M, Schöls L, Reetz K, Erdlenbruch F, Jacobi H, Infante J, Riess O, Klockgether T, ESMI study group, Faber J, Hübener-Schmid J.   +29 more
europepmc   +1 more source